KalVista Pharmaceuticals
KALV
KALV
128 hedge funds and large institutions have $640M invested in KalVista Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 45 increasing their positions, 35 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 24
1.22% less ownership
Funds ownership: 111.68% → 110.46% (-1.2%)
2% less funds holding
Funds holding: 130 → 128 (-2)
Holders
128
Holding in Top 10
6
Calls
$15.8M
Puts
$69K
Top Buyers
| 1 | +$12.5M | |
| 2 | +$8.7M | |
| 3 | +$6.71M | |
| 4 |
VA
VR Adviser
New York
|
+$5.24M |
| 5 |
JPMorgan Chase & Co
New York
|
+$4.4M |
Top Sellers
| 1 | -$13.5M | |
| 2 | -$8.92M | |
| 3 | -$6.99M | |
| 4 |
SVCM
Saturn V Capital Management
Austin,
Texas
|
-$3.48M |
| 5 |
State Street
Boston,
Massachusetts
|
-$3.43M |
